In another relatively light week for IPOs, only two companies are on deck -- a bank and a biotech name. More
-
-
Sponsored By:
-
Sponsored By:
Biotech
Including this topic: Biotech Movers
Biotech Movers: Acadia Jumps, Affymax Crashes
Last week, Acadia Pharmaceuticals rode the winds of good clinical results, while news of mass layoffs sent Affymax crashing again. More
The Early Investor Bird Does Catch the Worm
When I look for investment opportunities, I am drawn to some of the world's most innovative companies and these 5 biotech stocks fit the bill for investment More
New Breakout Target for Top Biotech Amgen
Amgen (NASDAQ:AMGN) broke from a small triangle on encouraging results for a new oncology drug. More
Make a Straightforward Play in Biotech
The iShares Nasdaq Biotechology Index Fund is a great way to get into biotechs ... just not now. It's due for a buyers' exhaustion break, so wait and keep watch. More
Biotech Movers: Spectrum, AEterna Among Big Losers
A stopped phase 3 trial grounded AEterna Zentaris and a downshift in guidance kneecapped Spectrum Pharmaceuticals last week. More
1 Stock to Buy, 1 Stock to Short: Biotech
A bullish head-and-shoulders bottom pattern in NPS Pharmaceuticals (NPSP) and a diamond top in United-Guardian (UG) offer two opposite opportunities in biotech. More
